Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

This publication has 36 references indexed in Scilit:

• Sudden cardiac death: the lost fatty acid hypothesis
  QJM: An International Journal of Medicine, 2006
• A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study
  Diabetic Medicine, 2006
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
  European Heart Journal, 2005
• The prevalence of abnormal glucose regulation in patients with coronary artery disease across EuropeThe Euro Heart Survey on diabetes and the heart
  European Heart Journal, 2004
• Fish and Long-Chain ω-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women
  Circulation, 2003
• Lack of benefit of dietary advice to men with angina: results of a controlled trial
  European Journal of Clinical Nutrition, 2003
• Biochemistry and molecular cell biology of diabetic complications
  Nature, 2001
• Insulin Therapy Improves Endothelial Function in Type 2 Diabetes
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias
  The Lancet, 1994
• Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988